Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01463
|
|||||
| Drug Name |
(-)-Epicatechin
|
|||||
| Synonyms |
(-)-Epicatechin; Epicatechin; 490-46-0; L-Epicatechin; (-)-Epicatechol; l-Acacatechin; (2R,3R)-2-(3,4-Dihydroxyphenyl)chroman-3,5,7-triol; Epicatechol; l-Epicatechol; (-)epicatechin; (2R,3R)-(-)-Epicatechin; UNII-34PHS7TU43; epi-Catechin; epi-Catechol; CCRIS 7097; EINECS 207-710-1; NSC 81161; Epicatechol, (-)-; CHEBI:90; 34PHS7TU43; PFTAWBLQPZVEMU-UKRRQHHQSA-N; (2R,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol; (-)-(2R:3R)-5,7,3',4'-Tetrahydroxyflavan-3-ol; AK105372; C15H14O6
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Becker muscular dystrophy [ICD11: 8C70.0] | Phase 2 | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C15H14O6
|
|||||
| Canonical SMILES |
C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)O
|
|||||
| InChI |
InChI=1S/C15H14O6/c16-8-4-11(18)9-6-13(20)15(21-14(9)5-8)7-1-2-10(17)12(19)3-7/h1-5,13,15-20H,6H2/t13-,15-/m1/s1
|
|||||
| InChIKey |
PFTAWBLQPZVEMU-UKRRQHHQSA-N
|
|||||
| CAS Number |
CAS 490-46-0
|
|||||
| Pharmaceutical Properties | Molecular Weight | 290.27 | Topological Polar Surface Area | 110 | ||
| Heavy Atom Count | 21 | Rotatable Bond Count | 1 | |||
| Hydrogen Bond Donor Count | 5 | Hydrogen Bond Acceptor Count | 6 | |||
| XLogP |
0.4
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:90
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | MRP2 | Transporter Info | Multidrug resistance-associated protein 2 | Substrate | [2] | |
| References | ||||||
| 1 | ClinicalTrials.gov (NCT03236662) (-)- Epicatechin Becker Muscular Dystrophy | |||||
| 2 | Transport and metabolism of the tea flavonoid (-)-epicatechin by the human intestinal cell line Caco-2. Pharm Res. 2001 Oct;18(10):1420-5. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.